A report in Circulation from the Framingham Heart Study, which compared acute myocardial infarction incidence in 9,824 men and women over four decades, has proposed an explanation for the apparent paradox of improved prevention, falling mortality rates but stable rates of hospitalisation.
The study found that over the past 40 years rates of acute infarction diagnosed by electrocardiogram decreased by 50%, whereas rates of infarction diagnosed exclusively by infarction biomarkers doubled. This “evolving” diagnosis of acute myocardial infarction, say the investigators, “offers an explanation for the apparently steady national AMI rates in the face of improvements in primary prevention”.
However, the investigators emphasise that this study – like others before it – highlights a “40-50%” reduction in heart disease mortality in the USA from 1968 to 2000 and a 50% decline in the incidence of heart attack when diagnosed by electrocardiogram. This, they propose, “implies that primary prevention efforts have influenced the incidence of AMI”. That the incidence of hospitalised infarction has not similarly declined is explained by the greater sensitivity of diagnostic acute myocardial infarction biomarkers; they note, for example, that the detection rate of heart attack by troponin was higher than in earlier decades.
Another explanation for the decline in acute myocardial infarction mortality rates may be found in a second report from the same Circulation issue. A cohort study of more than 13,000 residents of Worcester, USA, hospitalised with AMI found that the incidence of cardiogenic shock, the most common complication of acute myocardial infarction associated with fatality, declined throughout the 30-year study period. “The results of our study suggest that patients hospitalised with AMI in the 2000s were less likely to develop cardiogenic shock than greater Worcester residents hospitalized with acute myocardial infarction during earlier study years,” the investigators report. Cardiogenic shock results from failure of the ventricles to provide adequate circulation of blood.
Commenting on behalf of the European Society of Cardiology, Professor Frans Van de Werf, University Hospital, Leuven, Belgium, said: “These papers are indeed very helpful for understanding trends reported in recent epidemiological studies of AMI. The data underline the critical importance of the definition of an AMI. The increasing use of very sensitive and specific markers of myocardial necrosis (troponins) and the acceptance of a ‘universal definition’ of AMI have certainly influenced its detection and reporting. This also explains the increase in reporting of non-ST-elevations AMI. The decrease in hospital mortality in patients with cardiogenic shock in the last decade is most likely due to reperfusion therapy, in particular primary angioplasty. An aggressive approach to these patient is recommended in both the US and European guidelines.”
Source: European Society of Cardiology